Drug Insights

Is Clascoterone approved by the FDA?

5 July 2024
3 min read

Yes, clascoterone (Winlevi) is an FDA-approved topical cream for the treatment of acne vulgaris in patients aged 12 and older. Approved on August 26, 2020, it offers a novel mechanism of action by inhibiting androgen receptors in the skin, reducing oil production and inflammation associated with acne.

What is Clascoterone?

Clascoterone is a topical medication used for the treatment of acne vulgaris in individuals aged 12 and older. It is part of the drug class of topical acne agents and is applied directly to the skin in the form of a 1% cream.

How Clascoterone Works

Clascoterone works by blocking the effects of androgens (male hormones) on the skin's sebaceous (oil) glands. Androgens can increase oil production and inflammation, leading to acne. By inhibiting these hormones, clascoterone helps reduce acne lesions.

Administration and Dosage

Clascoterone is intended for topical use only and should not be ingested. The typical dosage involves applying a thin, uniform layer of the cream to the affected areas twice a day, once in the morning and once in the evening. It is important to follow the prescribed instructions carefully:

  • Wash your hands before and after applying the cream.
  • Clean the affected area with mild soap and water, then dry thoroughly.
  • Apply a small amount of the cream, rubbing it in gently.
  • Do not cover the treated skin with a bandage unless instructed by your doctor.

Potential Side Effects

Clascoterone can cause a range of side effects, from common to serious:

Common Side Effects:

  • Redness
  • Itching
  • Stinging or burning sensation
  • Swelling of treated skin
  • Dry or scaly skin

Serious Side Effects:

  • Severe itching, burning, peeling, or redness
  • High blood potassium levels (hyperkalemia)
  • Decreased adrenal gland hormones

If you experience any serious side effects, you should contact your doctor immediately.

Warnings and Precautions

  • Pregnancy and Breastfeeding: Consult your doctor if you are pregnant or breastfeeding.
  • Eczema or Skin Problems: Inform your doctor if you have a history of eczema or other skin conditions.
  • Avoidance: Do not apply clascoterone to open wounds, eczema-affected areas, or sunburned skin. Avoid getting the cream in your eyes, mouth, nose, vagina, or rectum.

How to obtain the latest development progress of all drugs?

In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Idorsia's JERAYGO: Europe's First and Only ERA Approved for Resistant Hypertension
Latest Hotspot
3 min read
Idorsia's JERAYGO: Europe's First and Only ERA Approved for Resistant Hypertension
5 July 2024
Idorsia’s JERAYGO (aprocitentan) approved in Europe as the first and only ERA for resistant hypertension treatment.
Read →
Is Oliceridine approved by the FDA?
Drug Insights
3 min read
Is Oliceridine approved by the FDA?
5 July 2024
Approved on August 7, 2020, oliceridine (Olinvyk) is intended for patients who have not found relief with other treatments.
Read →
TauRx Applies for UK Marketing Authorisation for HMTM to Treat Alzheimer's Disease
Latest Hotspot
3 min read
TauRx Applies for UK Marketing Authorisation for HMTM to Treat Alzheimer's Disease
5 July 2024
TauRx Pharmaceuticals Ltd has revealed the filing of a Marketing Authorisation Application in the UK for hydromethylthionine mesylate (HMTM).
Read →
Is Risdiplam approved by the FDA?
Drug Insights
3 min read
Is Risdiplam approved by the FDA?
5 July 2024
risdiplam FDA approval on August 7, 2020, has provided new hope and convenience for individuals affected by SMA.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.